Synthesis and stability test of radioimmunoconjugate 177Lu-DOTA-F(ab′)2-trastuzumab for theranostic agent of HER2 positive breast cancer

by Sandra Hermanto, Ratna Dini Haryuni, Martalena Ramli, Abdul Mutalib, Sumi Hudiyono
Published 2016-10-01

Preparation of (177Lu-DOTA)n-PAMAM-[Nimotuzumab-F(ab’)2] as a Therapeutic Radioimmunoconjugate for EGFR Overexpressed Cancer Treatment

by Titis Sekar Humani, Sutari, Triningsih, Martalena Ramli, Rien Ritawidya, Ratna Dini Haryuni
Published 2017-12-01